PLAY PODCASTS
Empowering Patients and Their Families to Solve Rare Disease Mysteries: Dr. Lukas Lange, CEO & Co-Founder of Probably Genetic
Episode 464

Empowering Patients and Their Families to Solve Rare Disease Mysteries: Dr. Lukas Lange, CEO & Co-Founder of Probably Genetic

As we’ve learned on previous episodes of Raise the Line, people dealing with rare diseases usually wait 4-7 years before receiving a diagnosis, during which time their condition can deteriorate significantly. Shortening this “diagnostic odyssey” is the mission of today’s guest, Lukas Lange, and in an interesting twist, he’s doing it by involving the patients themselves. The company he co-founded, Probably Genetic, has developed a system that starts with rare disease patients, or the parents of children with rare conditions, describing the symptoms involved on a website. “We run algorithms on that data in real time as you're on the website and if the algorithms think that this person might have a specific genetic disease, then we have a whole telemedicine system built in the background where we process that information and you get your test kit within about 48 hours of being on the website,” he explains to host Hillary Acer. Once the at-home test results are processed, a genetic counseling session is conducted via telemedicine. Tune in to find out why Lange believes having this knowledge is powerful for patients even if there may be no treatment available yet for their condition, and how it may be useful down the road with clinical trial recruitment, real world evidence tracking, and even early stage R&D for treatments. Mentioned in this episode: https://www.probablygenetic.com/

Raise the Line · Lukas Lange, Hillary Acer

March 21, 202428m 30s

Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

As we’ve learned on previous episodes of Raise the Line, people dealing with rare diseases usually wait 4-7 years before receiving a diagnosis, during which time their condition can deteriorate significantly. Shortening this “diagnostic odyssey” is the mission of today’s guest, Lukas Lange, and in an interesting twist, he’s doing it by involving the patients themselves.  The company he co-founded, Probably Genetic, has developed a system that starts with rare disease patients, or the parents of children with rare conditions, describing the symptoms involved on a website. “We run algorithms on that data in real time as you're on the website and if the algorithms think that this person might have a specific genetic disease, then we have a whole telemedicine system built in the background where we process that information and you get your test kit within about 48 hours of being on the website,” he explains to host Hillary Acer. Once the at-home test results are processed, a genetic counseling session is conducted via telemedicine. Tune in to find out why Lange believes having this knowledge is powerful for patients even if there may be no treatment available yet for their condition, and how it may be useful down the road with clinical trial recruitment, real world evidence tracking, and even early stage R&D for treatments.

Mentioned in this episode: https://www.probablygenetic.com/

If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Topics

drug costsat-home testingpharmacy benefit managersdrug developmentcontinuing educationjohns hopkins universityomicronlukas langedoctorsmedical degreescoronavirushome caredigital healthhealth insurancewearablesfrontline providersosmosis from elsevierpfizerfdagovernment policypsilocybinmedicareraise the linevirusmachine learningeducation innovationpharmaceuticalshospital staysinterviewnursing schoolflatten the curvemichael carreseelsevierai100000 genome projecthealthcare entrepreneursnursing cmenursesgenetic counselingprimary carehealthcare capacityhealthcare reformbig pharmaastra zenecadiagnostic odysseycovid-19rare disordershealthcare workforceexpertsspace repetitionmedical educationnursing shortagelsdmedicaidlearning sciencelearning sciencegene editingvalue-based caretechnologyflipped classroommedicare advantagenursing educationsolutionsphysician shortageprovider burnoutcdcepidemicosmosisprobably geneticdelta variantremote monitoringhealthcare systemmark cubanosmosis.orgdecision supportrare diseasesvirus outbreakonline educationallied health professionspublic policycovid19edtechshiv gaglanimdmamodernaphysician assistant educationvivian leechelsea clintonpodcastsnursing degreepsychedelicshospital systemspublic healthpublic healthdr. ashish jhavaccineseric topolyear of the zebradental educationtestingcenters for disease controlpsychedelic-assisted therapyhealth professionspandemicjohnson & johnsontelehealth